Abstract
Aim:
To investigate the modulation of liver cytochrome P450 1A2 (CYP1A2) expression by giving flutamide to adult rats.
Methods:
Rats were given 50, 100, and 200 mg/kg po of flutamide for 2 weeks. Liver CYP1A2 mRNA was measured using reverse transcription-polymerase chain reaction. CYP1A2 protein was detected using immunoblotting. CYP1A2 activity was assayed using high performance liquid chromatography, with caffeine as the CYP1A2 substrate.
Results:
CYP1A2 mRNA levels after flutamide treatment at 100 mg/kg and 200 mg/kg were, respectively, 1.86 and 3.11-fold higher than those of the control. Correspondingly, CYP1A2 protein increased 1.78 and 2.89-fold and CYP1A2 activity increased approximately 1.65 and 2.83-fold, respectively, relative to controls. Flutamide treatment at 50 mg/kg had no significant effect on CYP1A2 mRNA, protein, or enzyme activity.
Conclusion:
Giving rats flutamide induced liver CYP1A2 expression in a dose-dependent manner.
Similar content being viewed by others
Article PDF
References
Neri RO, Florance K, Koziol P . A biological profile of a nonsteroidal antiandrogen, SCH13521(4′-nitro-3′trifluoromethyliso-butyranilide). Endocrinology 1972; 91: 427–37.
Neri RO, Monahan M . Effects of novel nonsteroidal antiandrogen on canine prostatic hyperplasia. Invest Urol 1972; 10: 123–30.
Labrie F, Dupont A, Cusan L, Manhes G, Bergeron N, Lacourciere Y . Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer. J Steroid Biochem 1989; 33: 817–21.
Chen DH, Kaung HL, Miller CM, Resnick MI, Marengo SR . Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 2004; 93: 637–50.
Pitts, WR Jr . The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer. BJU Int 2004; 93: 1119–20.
Andrade RJ, Lucena MI, Fernandez MC, Suarez F, Montero JL, Fraga E . Fulminant liver failure associated with flutamide therapy for hirsutism. Lancet 1999; 353: 983–6.
Caine M, Perlberg S, Gordon R . The treatment of benign prostatic hypertrophy with flutamide: a placebo controlled study. J Urol 1975; 114: 564–6.
Bonard M, Almeida S . Placebo-controlled double-blind study in human benign obstructive prostatic hypertrophy with flutamide. Eur Urol 1975; 2: 24–8.
Lubbert C, Wiese M, Haupt R, Ruf BR . Toxic hepatitis and liver failure under therapy with flutamide. Internist (Berl) 2004; 45: 333–40.
Ometz JL, Dupont A, Cusan L, Tremblay M, Suburu R, Lrmay M . Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med 1992; 92: 465–70.
Anjumath S, Michael M, Charles W . Metabolism of the antiandrogenic drugs (flutamide) by human CYP1A2. Drug Metab Dispos 1997; 25: 1298–304.
Wang HX, Li D, Xu CJ, Liu X . Flutamide-associated acute liver failure. Ann Ital Med Int 2003; 18: 250–3.
Aizawa Y, Ikemoto I, Kishimoto K . Flutamide-induced hepatic dysfunction in relation to steady-state plasma concentrations of flutamide and its metabolites. Mol Cell Biochem 2003; 252: 149–56.
Gonzales FJ, Liu SY, Yano M . Regulation of cytochrome P450 genes: molecular mechanism. Pharmacogenetics 1993; 3: 51–7.
Boobis AR, Gooderham NJ, Rich KJ, Zhao K, Edwards RJ, Murray BP, et al. Enzymatic studies of the activation of heterocyclic food mutagens in man. Princess Takamatsu Symp 1995; 23: 134–44.
Vazquez RM, Gil GL, Lopez SP, Aleman VS, Garcia PA . Liver toxicity associated with flutamide. An Med Intern 2004; 21: 307–8.
Williams AT, Burke RF . Carbon tetrachloride hepatotoxicity: an example of free radical-mediated injury. Semin Liver Dis 2000; 10: 279–84.
Kamataki T, Kitagawa H . Effects of lyophilization and storage of rat liver microsomes on activity of aniline hydroxylase, contents of cytochrome b5 and cytochrome P-450 and aniline-induced P-450 difference spectrum. Jpn J Pharmacol 1974; 24: 195–203.
Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54.
Casler WL, Menzies JA, Whitehouse LW, Moon TW . Detection of quantitative trait loci affecting caffeine metabolism by interval mapping in a genome-wide scan of C3H/HEJ × APNF2 mice. Drug Metab Dispos 1999; 27: 1375–80.
Sandhu P, Guo Z, Baba T, Martin MV, Turkey RH, Guengerich FP . Expression of modified human cytochrome P450 1A2 in Escherichia coli stabilization, purification, characterization, and catalytic activities of the enzyme. Arch Biochem Biophys 1994; 309: 168–77.
Zacharova LY, Gulyaeva LF, Lyakhovich VV . Rat hepatic CYP1A1 and CYP1A2 induction by menadione. Toxicol Lett 2005; 155: 253–8.
McManus ME, Burgess WE, Weronese ME, Huggett A, Quattrochi LC, Tukey RH . Metabolism of 2-acetylaminofluorene and ben-zopyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res 1990; 50: 3367–76.
Toyoshiba H, Walker NJ, Bailer AJ, Portier CJ . Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds. Toxicol Appl Pharmacol 2004; 194: 156–68.
Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF . Human cytochrome P450, the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 1989; 86: 7696–700.
Kadlubar PF, Hammons GK . The role of cytochrome P-450 in the metabolism of chemical carcinogens, in mammalian cytochromes P-450. Boca Raton (FL): CRC Press; 1987.
Walubo A, Barr S, Abraham AM, Coetsee C . The role of cytochrome-P450 inhibitors in the prevention of hepatotoxicity after paracetamol overdose in rats. Hum Exp Toxicol 2004; 23: 49–54.
Wang HX, Xu CJ, Li D . Influence of flutamide on liver biotransformation enzymes and antioxidation in rats. J Fudan Univ (Med Sci) 2001; 28: 299–302.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by Fudan University Innovation Foundation (No CQF303801).
Rights and permissions
About this article
Cite this article
Wang, Hx., Liu, X., Xu, Cj. et al. Induction of liver cytochrome P450 1A2 expression by flutamide in rats. Acta Pharmacol Sin 26, 1382–1386 (2005). https://doi.org/10.1111/j.1745-7254.2005.00211.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00211.x
Keywords
This article is cited by
-
Epithermal deposits in North Xinjiang, NW China
International Journal of Earth Sciences (2012)